Related Experiment Videos
Advanced glycation end-products: a review
1Dept of Medicine, University of Western Australia and West Australian Heart Researrch Institute, Perth, Australia.
Diabetologia
|March 29, 2001
Summary
Advanced glycation end-products (AGEs) are linked to diabetes complications. This review explores AGE formation, their role in diabetic complications, and challenges in detection and treatment.
Area of Science:
- Biochemistry
- Endocrinology
- Pathology
Background:
- Advanced glycation end-products (AGEs) are implicated in diabetes complications, but their causal role remains unclear.
- AGEs are a heterogeneous group of compounds formed through non-enzymatic reactions.
- Their accumulation is associated with microvascular (retinopathy, neuropathy, nephropathy) and macrovascular complications in diabetes.
Purpose of the Study:
- To review the chemistry and pathobiochemistry of AGE formation.
- To discuss the role of AGEs in diabetic complications and the concept of carbonyl stress.
- To highlight challenges in AGE detection and measurement, and review therapeutic agents.
Main Methods:
- Literature review of AGE formation, biochemistry, and clinical relevance.
- Discussion of AGEs in the context of aging, diabetes, and its complications.
- Analysis of current detection methods and therapeutic strategies, including aminoguanidine trials.
Main Results:
- AGEs formation involves complex chemical reactions, contributing to diabetic complications.
- Carbonyl stress is a proposed mechanism for AGE toxicity.
- Significant challenges exist in standardizing AGE detection and measurement.
Conclusions:
- AGEs play a significant role in the pathogenesis of diabetic complications.
- Further research is needed to clarify the causal relationship between AGEs and complications.
- Development of standardized detection methods and effective therapeutic agents is crucial.